Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

SEPN

+ Watchlist+ Portfolio

Septerna, Inc.

Regulated industryDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$40.02
52-Week Range
$22.78 – $53.34
Market Cap
$1.88B
P/E (TTM)
—
EPS (TTM)
-1.30
Dividend Yield
0.00%
Advanced Metrics
Price/Book
4.37
PEG Ratio
—
Return on Equity
-14.45%
Return on Assets
-7.48%
Gross Margin
100.00%
Operating Margin
-76.23%
Profit Margin
-61.29%
Current Ratio
4.84
Debt/Equity
0.05
Total Debt
$21.99M
Free Cash Flow
$-7.81M
Revenue Growth
-12.20%
Earnings Growth
—
Enterprise Value
$1.42B

Market Snapshot

About

Septerna, Inc. is a clinical-stage biotechnology company focused on discovering and developing oral small molecule drugs for G protein-coupled receptor targets. The company utilizes a proprietary Native Complex Platform to unlock challenging GPCR targets across various therapeutic areas. Septerna aims to create transformative medicines for patients with significant unmet medical needs.